SCHEMBL2867169

SCHEMBL2867169

C=CCCC/C=C/COC(C)C

nearest known ligand 0.45

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP3A4 P08684 2/20 0.33
MAPT P10636 2/20 0.33
USP2 O75604 1/20 0.33
LMNA P02545 1/20 0.33
RECQL P46063 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CYP2C9 P11712 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2867171 1.00 TSHR (0.36) TSHRALDH1A1CYP3A4MAPTUSP2
SCHEMBL875951 0.84 MAPT (0.38) TSHRALDH1A1CYP3A4MAPTUSP2
SCHEMBL10955082 0.84 USP2 (0.35) TSHRALDH1A1CYP3A4MAPTUSP2
SCHEMBL5435517 0.83 TSHR (0.33) TSHRALDH1A1CYP3A4MAPTUSP2
SCHEMBL14564236 0.81 LMNA (0.36) TSHRALDH1A1CYP3A4MAPTUSP2
SCHEMBL5435503 0.81 LMNA (0.36) TSHRALDH1A1CYP3A4MAPTUSP2
SCHEMBL5438123 0.77 LMNA (0.36) TSHRALDH1A1CYP3A4MAPTUSP2
SCHEMBL5438132 0.77 LMNA (0.36) TSHRALDH1A1CYP3A4MAPTUSP2
SCHEMBL8909446 0.76 LMNA (0.30) LMNA
SCHEMBL9346978 0.76 LMNA (0.30) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2003138-B1 METHOD FOR PRODUCING ALDEHYDE USING BISPHOSPHITE AND GROUP 8-10 METAL COMPOUND, AND SUCH BISPHOSPHITE KURARAY CO (JP) 2013-10-09 EP claimed
CN-101415717-B Method for producing aldehyde using bisphosphite and group 8-10 metal compound, and such bisphosphite KURARAY CO 2012-12-12 CN claimed
US-7745666-B2 Rreacting a nonconjugated diene having a double bond in an end and having from 6-20 carbon atoms with a carbon monoxide and hydrogen in the presence of a bisphosphite and a transition metal compound to provide an unsaturated acyclic aldehyde; KURARAY CO., LTD. (JP) 2010-06-29 US claimed
US-20090259073-A1 Rreacting a nonconjugated diene having a double bond in an end and having from 6-20 carbon atoms with a carbon monoxide and hydrogen in the presence of a bisphosphite and a transition metal compound to provide an unsaturated acyclic aldehyde; KURARAY CO., LTD (JP) 2009-10-15 US claimed
CN-101415717-A Method for producing aldehyde using bisphosphite and group 8-10 metal compound, and such bisphosphite KURARAY CO (JP) 2009-04-22 CN claimed
US-7491850-B2 Useful component of catalysts used in the hydroformylation of olefins with carbon monoxide and hydrogen; reaction under milder conditions KURARAY CO., LTD. (JP) 2009-02-17 US claimed
EP-2003138-A1 METHOD FOR PRODUCING ALDEHYDE USING BISPHOSPHITE AND GROUP 8-10 METAL COMPOUND, AND SUCH BISPHOSPHITE Kuraray Co., Ltd. (JP) 2008-12-17 EP claimed
EP-2003138-B1 METHOD FOR PRODUCING ALDEHYDE USING BISPHOSPHITE AND GROUP 8-10 METAL COMPOUND, AND SUCH BISPHOSPHITE KURARAY CO (JP) 2013-10-09 EP disclosed
CN-101415717-B Method for producing aldehyde using bisphosphite and group 8-10 metal compound, and such bisphosphite KURARAY CO 2012-12-12 CN disclosed
US-7745666-B2 Rreacting a nonconjugated diene having a double bond in an end and having from 6-20 carbon atoms with a carbon monoxide and hydrogen in the presence of a bisphosphite and a transition metal compound to provide an unsaturated acyclic aldehyde; KURARAY CO., LTD. (JP) 2010-06-29 US disclosed
EP-1728796-B1 BISPHOSPHITE AND PROCESS FOR PRODUCING ALDEHYDE COMPOUND WITH THE BISPHOSPHITE KURARAY CO LTD KURASHIKI PLANT (JP) 2010-03-17 EP disclosed
US-20090259073-A1 Rreacting a nonconjugated diene having a double bond in an end and having from 6-20 carbon atoms with a carbon monoxide and hydrogen in the presence of a bisphosphite and a transition metal compound to provide an unsaturated acyclic aldehyde; KURARAY CO., LTD (JP) 2009-10-15 US disclosed
CN-101415717-A Method for producing aldehyde using bisphosphite and group 8-10 metal compound, and such bisphosphite KURARAY CO (JP) 2009-04-22 CN disclosed
US-20050038273-A1 Method for telomerizing non-cyclic olefins OXENO OLEFINCHEMIE GMBH (DE) 2005-02-17 US disclosed
US-5004568-A Reacting With Carbon Monoxide Using A Group 8 Noble Metal Halide Catalyst And A Group 1B Metal Halide NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) 1991-04-02 US disclosed
US-4767574-A CATALYTIC WITH GROUP 8 NOBLE METAL HALIDE AND HALIDE COMPOUND NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) 1988-08-30 US disclosed
US-4675435-A CARBONYLATION OF ACYCLIC ALLYLIC ETHER NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) 1987-06-23 US disclosed
EP-0217407-A2 Carbonylation of allylic ethers to esters QUANTUM CHEMICAL CORPORATION (a Virginia corp.) (US) 1987-04-08 EP disclosed
US-4622416-A GROUP 8 HALIDE CATALYSTS NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) 1986-11-11 US disclosed
US-4146738-A ACTIVATED PALLADIUM TRIARYLPHOSPHINE CATALYST CHEMISCHE WERKE HUELS, AKTIENGESELLSCHAFT (DE) 1979-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090259073-A1 Rreacting a nonconjugated diene having a double bond in an end and having from 6-20 carbon atoms with a carbon monoxide and hydrogen in the presence of a bisphosphite and a transition metal compound to provide an unsaturated acyclic aldehyde; CBR1, RCN1, CYC1 TSHR 1996/4885ALDH1A1 72/4885CYP3A4 436/4885
US-20050038273-A1 Method for telomerizing non-cyclic olefins PCNA, TELO2, TTI1 TSHR 3017/4885ALDH1A1 3141/4885CYP3A4 1893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.